L'Oreal CEO discusses impact of weight loss drugs on beauty product sales
BBC · October 22, 2026Original source ↗
What happened
L'Oreal's CEO stated that the use of GLP-1 weight loss drugs is affecting sales in the beauty and skin care sectors. This trend has been identified as significant by the company.
Why it matters
The information highlights changes in consumer behavior that may impact the beauty industry.
How this story affects people
How does this story affect you if you are a consumer of beauty products?
The trend of increased weight loss drug usage may lead to changes in product availability or pricing in the beauty market, as companies like L'Oreal adjust their strategies in response to shifting consumer preferences.
Read a briefing based on your profile
The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.
Download on the App Store3 free Ripples in total. Read without an account. iPhone · iOS 26.0+ · United States
More stories
- BusinessAI stocks decline as global markets react to rising oil prices
- BusinessAirline industry sees increased fares and reduced flight options
- BusinessLockheed Martin signs agreement with Pentagon for F-35 jet production
- BusinessVance announces $1.3 billion investment in fertilizer manufacturing in Nebraska